within Pharmacolibrary.Drugs.S_SensoryOrgans.S01G_DecongestantsAndAntiallergics.S01GA03_Xylometazoline;

model Xylometazoline
  extends Pharmacolibrary.Drugs.ATC.S.S01GA03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>S01GA03</td></tr><td>route:</td><td>intranasal</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Xylometazoline is a topical nasal decongestant, acting as an alpha-adrenergic agonist. It is primarily used to relieve nasal congestion in conditions such as rhinitis, sinusitis, and the common cold. It is approved for short-term use and is widely available over the counter.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult population following intranasal administration. No published compartmental population pharmacokinetic studies exist for xylometazoline; values are inferred or estimated based on related information from similar topical nasal decongestants.</p><h4>References</h4><ol><li><p>Wellington, K, &amp; Jarvis, B (2001). Cetirizine/pseudoephedrine. <i>Drugs</i> 61(15) 2231–2242. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200161150-00009&quot;>10.2165/00003495-200161150-00009</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11772135/&quot;>https://pubmed.ncbi.nlm.nih.gov/11772135</a></p></li><li><p>Tuncay Tanriverdi, S, et al., &amp; Ozer, O (2024). Comprehensive evaluation of xylometazoline hydrochloride formulations: Ex-vivo and in-vitro studies. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 203 114466–None. DOI:<a href=&quot;https://doi.org/10.1016/j.ejpb.2024.114466&quot;>10.1016/j.ejpb.2024.114466</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39173937/&quot;>https://pubmed.ncbi.nlm.nih.gov/39173937</a></p></li><li><p>Ali, A, et al., &amp; Engblom, J (2019). Dehydration affects drug transport over nasal mucosa. <i>Drug delivery</i> 26(1) 831–840. DOI:<a href=&quot;https://doi.org/10.1080/10717544.2019.1650848&quot;>10.1080/10717544.2019.1650848</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31401887/&quot;>https://pubmed.ncbi.nlm.nih.gov/31401887</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Xylometazoline;
